Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung; Disease, Interstitial, With Fibrosis”

461 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 461 results

Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Not applicableStudy completedNCT05670587
What this trial is testing

A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Not applicableStudy completedNCT01600352
What this trial is testing

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
Singapore General Hospital 20
Not applicableLooking for participantsNCT07269262
What this trial is testing

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Medical University of South Carolina 170
Not applicableStudy completedNCT03050255
What this trial is testing

Short-term Effects of Supplemental Oxygen in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Schön Klinik Berchtesgadener Land 53
Not applicableUnknownNCT04789395
What this trial is testing

Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT

Who this might be right for
Ozone Therapy for Covid 19 Pneumonia Patients
Gaziosmanpasa Research and Education Hospital 25
Large-scale testing (Phase 3)Ended earlyNCT01777737
What this trial is testing

Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 3
Not applicableEnrolling By InvitationNCT06629623
What this trial is testing

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chu Hongling 310
Not applicableUnknownNCT03440489
What this trial is testing

Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary Fibrosis

Who this might be right for
Interstitial Lung DiseaseSkeletal Muscle Dysfunction
Assiut University 1
Not applicableStudy completedNCT04864990
What this trial is testing

Dyspnea and Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University Hospital, Lille 51
Early research (Phase 1)Looking for participantsNCT06482190
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd 72
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Early research (Phase 1)UnknownNCT04537130
What this trial is testing

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge

Who this might be right for
Pulmonary FibrosisCovid19
Instituto Oncológico Dr Rosell 40
Testing effectiveness (Phase 2)Study completedNCT06764862
What this trial is testing

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Haisco Pharmaceutical Group Co., Ltd. 186
Not applicableStudy completedNCT01772667
What this trial is testing

Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Schön Klinik Berchtesgadener Land 51
Testing effectiveness (Phase 2)Study completedNCT01170065
What this trial is testing

Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 198
Testing effectiveness (Phase 2)Study completedNCT02538536
What this trial is testing

Evaluate the Safety and Tolerability of PBI-4050 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Liminal BioSciences Ltd. 41
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Load More Results